Elanco Animal Health announced plans to establish Elanco Ventures, a corporate venture capital platform focused on innovation in animal health. And Elanco Ventures will be backed by a $25 million multi-year commitment and is expected to launch in late 2026.
The platform will initially focus on strategic investments in therapeutic advancements and supportive technologies across the animal health sector.
Elanco said the new venture platform will help the company expand visibility into emerging technologies and partner with startups developing solutions for pets, livestock, and broader animal health needs.
The fund may also explore opportunities within the broader One Health landscape, where animal, human, and plant health intersect.
Elanco Ventures is expected to leverage partnerships within the One Health Innovation District in Indianapolis, which is anchored by Elanco and Purdue University. The district is designed to bring together life sciences companies, researchers, entrepreneurs, diagnostics, care, commercialization, and talent in one connected ecosystem.
Elanco Ventures will be overseen by Eric Steager, an experienced corporate venture capital leader. The platform will focus on early-stage companies, prioritizing Pre-Seed, Seed, and Series A stages of development.
Elanco Animal Health is a global animal health company focused on products and services that prevent and treat disease in farm animals and pets.
KEY QUOTES:
“From pets to protein – the animal health industry has never been more relevant than it is today. Innovation is happening outside of the boundaries of any single company. Elanco Ventures allows us to strategically leverage the startup landscape to expand our visibility into a range of emerging technologies that help us meet pet owners’ evolving expectation of care and the increasing global demand for protein.”
Jeff Simmons, President and CEO of Elanco
“Elanco Ventures embodies our commitment to partnership and innovation. By identifying promising startup technologies and collaborating with the One Health Innovation District, we are better positioned to fast-track innovation that can redefine the future of animal health.”
Tim Bettington, Executive Vice President, Center of Strategic Growth at Elanco
